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Objective To describe the diagnosis and outcomes of tuberculous lymphadenitis in a low HIV-seroprevalence
population at a hospital in Riyadh, Saudi Arabia.
Methods Retrospective case series of tuberculous lymphadenitis from 1983 to 1998 were examined.
Results There were 99 cases with a median age of 38 years and a female preponderance (female/male ratio of
1.3 : 1). Eighty per cent had cervical involvement and 36% had systemic symptoms. Eighty-nine per cent had
their lymphadenopathy for more than 1 month. The diagnostic yield of tuberculin skin testing was 83%, of
chest X-ray was 27%, of ﬁne-needle aspiration was 46%, and of excisional lymph node biopsy was 97%. Only
one-third of patients received a tuberculin test. There was no signiﬁcant difference in outcome between 6 and
9 months of chemotherapy, and paradoxical enlargement of nodes occurred in only 6%.
Conclusions Tuberculous lymphadenitis in our study population was predominantly cervical in location. The
diagnostic yield of FNA was lower than that reported in the literature, and might be improved by more
frequent tuberculin skin testing, multiple aspirations of lymph nodes, or use of excisional biopsy as the initial
diagnostic procedure. Most patients responded well to chemotherapy, with few complications.
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INTRODUCTION
Lymphadenitis is the commonest form of extrapulmonary
tuberculosis [1], and tuberculous lymphadenitis is among the
commonest causes of peripheral lymphadenopathy in the
developing world [2]. In developed countries, tuberculous
lymphadenitis is usually a disease of the foreign-born [3–5], but
in developing countries it is an endemic disease of young adults
with a female preponderance [6].
Tuberculous lymphadenitis typically presents as painless,
ﬁrm enlargement of the lymph nodes. The usual diagnostic
tests are ﬁne-needle aspiration (FNA) and/or excisional biopsy
of a lymph node, although the diagnosis is sometimes established
by the demonstration of concomitant pulmonary tuberculosis.
It has been suggested that FNA should be the initial diagnostic
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test in developing countries with a high prevalence of tubercu-
losis because it is sufﬁciently sensitive and avoids the need
for hospitalization and general anesthesia; however, excisional
biopsy is preferred as the initial test in developed countries [2].
There are few reports of tuberculous lymphadenitis from the
Middle East [7–10]. This report describes the presentation,
diagnosis, and treatment of tuberculous lymphadenitis from
1983 to 1998 at a Saudi Arabian secondary- and tertiary-care
hospital which serves a predominantly Bedouin populationwith
low HIV seroprevalence.
MATERIALS AND METHODS
The King Fahad National Guard Hospital, a 500-bed facility
situated in Riyadh, Saudi Arabia, provides secondary and ter-
tiary care to National Guard soldiers and their dependents. Most
National Guard soldiers are Bedouins and come from closely
knit tribes and families. The HIV seroprevalence from July
1995 to December 1997 among 22 229 blood donors at the
hospital was 0%; blood donors include soldiers and relatives of
patients requiring blood products. Because of the extremely
low prevalence of HIV infection in the referral population,
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HIV serology is not routinely done in patients diagnosed with
tuberculosis. This is a report of a retrospective series of tubercu-
lous lymphadenitis cases managed at the hospital from 1983 to
1998.
Cases were identiﬁed using the discharge diagnosis database
from the Medical Records Department, a database of histology
reports from the Pathology Department, and a database of
positive Mycobacterium tuberculosis cultures from the Micro-
biology Laboratory. A conﬁrmed case of tuberculous lymph-
adenitis was deﬁned by a positive culture for M. tuberculosis, a
positive acid-fast bacillus (AFB) smear, or the presence of case-
ating granulomas in histologic sections or cytologic smears with
no clinical evidence of other infectious or non-infectious
diseases. All lymph node biopsies were done by open excision.
Some cases were diagnosed by incision and drainage of a caseous
lymph node and AFB smear and culture of the pus. M. tubercu-
losis was cultured in Bactec broth and/or Lowenstein–Jensen
agar and identiﬁed according to standard biochemical tests.
Charts were reviewed and the following data extracted: age,
sex, presence of local or constitutional symptoms, body site of
lymphadenitis, duration of lymph node enlargement, sites of
extranodal involvement, chest radiologic ﬁndings, tuberculin
skin test results, results of FNA and/or excisional lymph node
biopsy, and details of antituberculous chemotherapy. The dur-
ation of lymph node enlargement was deﬁned as acute (less
than 1 month), subacute (1–3 months), or chronic (greater than
3 months). A tuberculin skin test induration size−10mm was
considered to be a signiﬁcant positive reaction. Long-term
follow-up of treatment results was limited by the nomadic
lifestyle of the study population.
All statistical analyses were generated using Stata version 4.0
(Stata Corporation, College Station, Tx, USA). The statistical
signiﬁcance of categorical variables was assessed by Fisher’s
exact test, and that of continuous variables was assessed by the
two-sample Wilcoxon rank sum test.
RESULTS
Ninety-nine cases of tuberculous lymphadenitis were evaluated
from 1983 to 1998. The mean number of cases per year was
6.2 and no temporal trend in incidence was observed. The sex
and age distribution of cases is shown in Figure 1. There were
43 males and 56 females, and the median age was 38 years
Figure 1 Tuberculous lymphadenitis cases by age and sex (n=99).
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(range 1–78 years); ﬁve patients were less than or equal to age
12 years. The median age was not signiﬁcantly different for
males and females (P=0.73). Ninety-six of the cases were Saudi
nationals and three were Filipino nationals. Only one of the 99
cases was tested for HIV antibodies; this patient was seropositive
and presented with concurrent tuberculous lymphadenitis and
visceral leishmaniasis.
The most frequent presentation of tuberculous lymph-
adenitis was sole involvement of the cervical lymph node region
(n=63). In addition, 16 patients had involvement at another
site in addition to the neck (Table 1). Cervical involvement
could be accompanied by axillary, intrathoracic, intra-abdomi-
nal, or inguinal lymphadenitis. Twenty other patients with
lymphadenitis did not have cervical involvement (data not
shown).
Ninety-eight of 99 (99%) patients had local symptoms or
signs on presentation, and 36 of 99 (36%) had constitutional
symptoms (fever, night sweats, weight loss). Lymph node
enlargement was acute in six of 99 (11%) patients, subacute in
23 of 99 (23%) patients, and chronic in 27 of 99 (27%) patients.
A sinus tract was observed in six cases.
The tuberculin skin test was signiﬁcantly reactive (−10mm
induration) in 29 of 35 (83%) patients tested. The chest radio-
graph was normal in 70 patients but revealed old ﬁbrosis in
four, parenchymal disease suggestive of tuberculosis in seven,
and intrathoracic lymphadenopathy in 15 (Table 2). Four of
seven patients with parenchymal abnormalities had Myco-
bacterium tuberculosis isolated from sputum, and one was culture
positive from a lung biopsy.
The method of diagnosis in 99 cases of tuberculous lymph-
adenitis was as follows: positive excisional lymph node biopsy
alone (n=57), negative FNA but positive excisional lymph
node biopsy (n=19), positive FNA alone (n=15), both positive
FNA and excisional lymph node biopsy (n=1), AFB-smear-
positive lung biopsy (n=1), AFB smear-positive and/or M.
tuberculosis culture-positive sputum (n=4), and AFB smear-
positive and/orM. tuberculosis culture-positive caseous material
obtained by incision and drainage at a lymph node site (n=2).
Table 1 Presentations of tuberculous cervical lymphadenitis
Presentation No. %
Cervical, bilateral 9 11.4
Cervical, midline 4 5.1
Cervical, right 32 40.5
Cervical, left 4 17.7
Cervical, unspeciﬁed 4 5.1
Cervical + thoracic 13 16.4
Cervical + abdominal 1 1.3
Cervical + axillary + inguinal 1 1.3
Cervical + thoracic + abdominal 1 1.3
Total 79 100
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Table 2 Chest radiographic ﬁndings in tuberculous
lymphadenitis
Radiographic ﬁnding No. %
Normal 70 72.9
Fibrosis 4 4.2
Parenchymal diseasea 7 7.3
Hilar/mediastinal/paratracheal nodes 15 15.6
Total 96 100
a Four patients had sputum and one patient had lung biopsy that
was positive for acid-fast-bacilli and/or M. tuberculosis.
The yield of diagnostic tests in tuberculous lymphadenitis is
shown in Table 3. Excisional lymph node biopsy was diagnostic
in 76 of 78 (97%) cases, incision and drainage was diagnostic in
two of two (100%) cases, and FNA was diagnostic in 16 of 35
(46%) cases. Among 35 cases receiving FNA, both AFB smear
and tuberculosis culture were performed in 17, neither were
performed (i.e. cytologic examination only) in 13, AFB smear
only was performed in four, and tuberculosis culture only was
performed in one. The yield ofM. tuberculosis culture exceeded
that of AFB smear for both FNA and excisional lymph node
biopsy. Non-tuberculous mycobacteria were not isolated. Anti-
microbial susceptibility was available for M. tuberculosis isolates
in 27 patients; no isolates exhibited primary resistance to ﬁrst-
line antituberculous drugs.
All 99 cases of tuberculous lymphadenitis received anti-
tuberculous chemotherapy. Eighteen patients received two
drugs, 67 received three drugs, 13 received four drugs, and one
received ﬁve drugs. Ninety-eight of 99 patients received an
isoniazid–rifampin-containing regimen. Among 86 patients
receiving isoniazid, 16 patients received at least 12 months of
treatment, 52 received at least 9 months of treatment, and 73
received at least 6 months of treatment. The median duration
of treatment with isoniazid was 9 months (range, 2–30 months;
Table 3 Diagnostic tests in tuberculous lymphadenitisa
Procedure No. positive Total % positive
Chest radiograph 26 96 27
Tuberculin skin test 29 35 83
Fine-needle aspirate
Histology 11 35 31
AFB smear 7 21 33
TB culture 9 18 50
Excisional lymph
node biopsy
Histology 76 78 97
AFB smear 45 77 58
TB culture 38 61 62
Incision and drainage 2 2 100
aSome patients had more than one kind of diagnostic procedure.
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n=86), with rifampin was 9 months (range, 2–30 months;
n=85), with pyrazinamide was 3 months (range, 2–30 months;
n=49), with ethambutol was 5.5 months (range, 1–12 months,
n=32), and with streptomycin was 1 month (range, 1–2 mon-
ths; n=6). There was no difference in cure rate among those
who received 9 or more months of therapy and those who
received 6 or more months but less than 9 months of therapy
(P=1.00). The overall treatment results in the 99 patients were
as follows: 73 patients were cured, one patient relapsed, and 25
had incomplete follow-up. The patient who relapsed had been
treated with isoniazid, rifampin, and pyrazinamide for 9 months
but had a recurrence of a neck abscess; biopsy revealed chronic
inﬂamed muscle and granulomatous inﬂammation of a lymph
node with no AFB seen. This patient was restarted on anti-
tuberculous chemotherapy and cured by retreatment.
Of 99 patients who were treated, six (6%) had enlargement
of their lymph nodes after starting chemotherapy. Treatment
outcomes in these patients with paradoxical enlargement
included three cures, one bacteriologic relapse, and two patients
with incomplete follow-up.
DISCUSSION
In this 16-year series of 99 patients with tuberculous lymph-
adenitis, no secular trend in incidence was observed. The pat-
ients were young with a median age of 38 years, and there was
a slight preponderance of females (female/male ratio of 1.3 : 1),
as noted in other studies [6,7,11]. Dandapat et al speculate that
the female preponderance reﬂects a greater consciousness of
their physical appearance which leads them to seek medical
attention [6].
The most common clinical presentation of tuberculous
lymphadenitis at our hospital was sole involvement of the cer-
vical lymph nodes (63 of 99 patients, 64%), with the right
side more frequently involved than the left side. Sixteen other
patients had cervical lymphadenitis plus lymphadenitis at other
sites, so, in total, 79 of 99 (80%) patients had cervical involve-
ment. Other studies in developing countries have revealed the
predominance of the cervical site, with a prevalence of neck
involvement ranging from 65% to 89% [6,9,12]. Cervical
lymphadenitis can arise when inhaled tubercle bacilli deposit in
the tonsils or pharynx and spread by the lymphatics to the
regional nodes [13]. Alternatively, pulmonary infection may be
complicated by hematogenous seeding of cervical nodes [13].
Perhaps the existence of dual pathways of infection explains the
predominance of the cervical location in tuberculous lymph-
adenitis.
The absence of constitutional symptoms does not make a
diagnosis of tuberculous lymphadenitis less likely. Only 36% of
our cases had constitutional symptoms, and in other studies the
prevalence of constitutional symptoms ranges from 33% to 85%
[6,11,14].
140 Clinical Microbiology and Infection, Volume 6 Number 3, March 2000
Only one-third of the patients received a skin test, of whom
83% had a signiﬁcant reaction. In other studies, 74–96% of
patients with tuberculous lymphadenitis had positive skin tests
[4,6,7,14]. Thus, tuberculin skin testing was underutilized in
the investigation of lymphadenitis at our hospital, despite its
reasonable sensitivity, and this may have been due to the per-
ception that such testing has less diagnostic value in a country
with universal BCG vaccination in early childhood. However,
tuberculin reaction size following BCG vaccination wanes with
time, and should generally not confound the interpretation of
a Mantoux test in adults [15] or children [16].
In a prospective study utilizing excisional biopsy as the diag-
nostic standard, Lau et al [17] observed that the diagnostic yield
of FNA was considerably enhanced in the presence of a strong
tuberculin skin test reaction. For FNA alone, the sensitivity was
77% and the speciﬁcity was 70%, but for the combination of
FNA and Mantoux test, the sensitivity was 90% and the speci-
ﬁcity was 84%. Since the diagnostic yield of FNA in our study
was relatively low (see below), the addition of Mantoux testing
may allow more patients to be diagnosed without the need to
proceed to excision biopsy.
Excisional lymph node biopsy had the highest diagnostic
yield in this series (97%), and the majority of cases were diag-
nosed by excisional biopsy without antecedent FNA. Because
this study was retrospective, it is difﬁcult to determine why
more patients did not initially receive FNA. Nonetheless, in 35
patients who had initial FNA of a lymph node, the diagnosis
was established in only 16 (46%); this compares with an FNA
diagnostic yield of 50–83% in other studies in developing coun-
tries [6,7,18]. In the 19 patients in whom FNA was not diag-
nostic, subsequent excisional biopsy established the diagnosis in
100%. Part of the reason for the disappointing yield of FNA
may be the fact that less than half of all FNA specimens were
processed for both AFB smear and tuberculosis culture, possibly
because of an inadequate quantity of aspirated material. Failure
to perform both tests will certainly reduce the diagnostic yield
of FNA, because culture of FNA specimens is more sensitive
than AFB smear for detecting M. tuberculosis [10,18–20]. In
addition, FNA is more likely to introduce sampling error than
excisional biopsy. The low yield of FNA at our hospital might
be increased by obtaining multiple aspirations of the lymph
nodes during FNA. It was not possible from the medical record
review to determine how many aspirates were taken from each
patient who received FNA.
Almost all patients were treated with a regimen containing
at least isoniazid and rifampin, and the median duration of
administration was 9 months for these agents. No signiﬁcant
difference in cure rate was observed between those patients
who received at least 9 months of treatment and those who
received at least 6 months but less than 9 months of treatment
with isoniazid, rifampin, and another ﬁrst-line drug. This result
agrees with other studies that have shown equal effectiveness of
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9-month and 6-month regimens in the treatment of tuberculous
lymphadenitis [21–23].
Paradoxical enlargement or appearance of new lesions has
been described during the treatment of brain tuberculomas
[24,25] and tuberculous lymphadenitis [21]. The incidence of
paradoxical enlargement or new lymph node development var-
ies from 10% to 23% [12,26], and is thought to represent
hypersensitivity to tuberculoprotein rather than bacteriologic
relapse. Management of paradoxical lymph node enlargement
can include observation, corticosteroid administration, or sur-
gical excision. Only 6% of patients in the present study had
paradoxical enlargement of nodes during or after chemo-
therapy, and only one of these patients had a bacteriologic
relapse. No primary drug resistance was encountered in the
patients tested.
Mediastinal lymphadenopathy was observed in 9% of our
cases, and in developed countries is likely to raise the possibility
of malignant lymphoma. However, in developing countries,
tuberculosis is a more common cause of mediastinal lym-
phadenopathy, and if mediastinoscopy is not available and no
other lymph nodes can be easily biopsied, then a trial of empiri-
cal antituberculous therapy is justiﬁed. Reduction of medias-
tinal lymph node size after 2–3 months of antituberculous
treatment supports the diagnosis and eliminates the need to
perform mediastinoscopy.
In conclusion, mycobacterial lymphadenitis in this study was
predominantly caused by M. tuberculosis sensitive to ﬁrst-line
antituberculous drugs. Cervical and intrathoracic lymph nodes
were commonly involved and the minority of patients had
constitutional symptoms. Excisional biopsy was superior to
FNA for diagnosis. A good therapeutic response with a low
frequency of complications was seen with 6- and 9-month
treatment regimens.
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